Built at the intersection of patient experience, clinical reality, and aging biology.

I was the kind of person longevity influencers point to as “optimized.”

Low-carb diet. Daily exercise. Sauna. Cold exposure. CGM data. A deep supplement stack. Normal standard labs. Rock-bottom hsCRP. No insulin resistance.

By the usual wellness metrics, I looked protected.

Then came vague chest discomfort. The first workup was clean. Old mid-back injuries and possible anxiety were what the doctors thought. But something didn’t feel right, and I pushed for the CT coronary angiogram that finally showed the problem:

An 80% blockage in my right coronary artery at 44.

The denial came first. Then the classic “why me?” Then the clarity: I needed to begin analyzing every aspect of my health routine the same way I approached research in the lab. The whole optimization playbook needed to get deconstructed and run through an evidence pipeline.

Mechanism is not proof. A normal biomarker — or even a zero calcium score — is not always a clean artery. And even a high-functioning medical system can miss obstructive coronary disease in someone with extreme health literacy, persistence, and access.

If it could miss me, it can miss a lot of people.

My formal research training is in bioinformatics, computational biology, molecular biology, and cancer epigenetics.

I have an MS in Bioinformatics & Computational Biology through the University of Minnesota / Mayo Clinic joint program, and am a PhD candidate in the same program. My published research background comes from epigenetics and translational oncology work at the University of Minnesota Hormel Institute, including a cancer epigenetics paper in Neoplasia.

That background matters because aging biology and cancer biology share a lot of terrain: epigenetic drift, mitochondrial dysfunction, chronic inflammation, altered metabolism, impaired repair, telomere biology, and damaged cells escaping normal restraint.

The DNA methylation clocks used in aging research are built on the same biological substrate I trained on in cancer epigenetics: methylation patterns across the genome.

So I don’t read longevity claims as isolated headlines. I read them as pathway claims, measurement claims, biomarker claims, and evidence-quality claims. I analyze the methods section of the paper first.

Before I form an opinion about an intervention, I want to know: What is the mechanism? Was it shown in humans? What dose? What form? What moved? What didn’t? Who funded the study? And does the result actually map onto the biology of aging?

I’m a Mayo Clinic Emergency Department RN and Certified Emergency Nurse, currently completing my APRN-FNP at Duke with a cardiology focus.

Three-plus years at the bedside in a high-acuity emergency department teaches you things a textbook does not.

The difference between a lab value and the person trying to understand what it means.

The difference between statistical significance and clinical significance.

The difference between what the data shows and what the patient actually heard.

In medicine, the doctor’s explanation is often technically correct but emotionally unusable. They explain the diagnosis, often filled with jargon, ask if there are questions, and get a polite no from a patient who is still trying to process what just happened.

Then the nurse stays behind.

That is where the translation happens. Plain language. Real context. Fewer assumptions. More attention to what the patient actually needs to understand before they can make a decision.

That posture shapes Calibrated Signal.

The goal is not to make complex biology sound simple when it isn’t. The goal is to make it understandable without making it shallow.

Calibrated Signal is the nurse who stayed behind.

You should leave understanding the actual claim, not feeling like you should have understood it.

I started experimenting on myself in my late thirties, when the reality of aging first started creeping in.

Sleep studies. Continuous glucose monitors. Wearables. EEG arrays. Supplement protocols. Fasting windows. Sauna. Cold exposure. Breathing work. The whole quantified-self apparatus.

I was already deep down this road when I discovered my blockage. I most definitely wasn’t doing it all right.

When I write about an intervention, I usually know what it feels like to actually do it. I know which protocols are interesting on paper but unsustainable in real life. I know which measurements change behavior, which ones create noise, and which devices produce expensive theater.

“Biohacker” is not a label I love. But the practice underneath it is real: disciplined self-experimentation, careful measurement, n-of-1 trials, and a willingness to pay attention to your own biology.

Used well, that mindset can be useful.

Used poorly, it can become a story you tell yourself about control.

That is the lesson I learned the hard way. Self-tracking can reveal patterns, but it can also miss the thing that matters most. Optimization is not the same as protection.

I still believe in measurement. I just no longer mistake measurement for certainty.